<DOC>
	<DOCNO>NCT02592096</DOCNO>
	<brief_summary>To investigate safety , tolerance , dynamic percolation model single dose usage pazufloxacin mesilate ear drop patient acute suppurative otitis medium chronic suppurative otitis medium</brief_summary>
	<brief_title>Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Pazufloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<criteria>1 . Aged 1865 year old , gender ; 2 . Patients acute chronic suppurative otitis medium , need treat partially antimicrobial agent ; 3 . Written inform consent form . 1 . Allergic quinolones antibiotic severe allergic constitution ; 2 . Not able collect otorrhea trial ; 3 . High severity need combine antibiotic treatment ; 4 . Induced pathogen , e.g . : fungus , virus ( myringitis bullosa ) ; 5 . Combined otitis externa ( e.g . : ear cellulitis , mumps ) , intracranial extracranial complication ( meningitis , cerebral abscess , thrombophlebitis sigmoid sinus , Bezold 's abscess , ear subperiosteal abscess ) ; 6 . Severe disease cerebral , cardiopulmonary , renal hepatic , circulatory system ; 7 . Lifethreatening disease , e.g . : malignant tumor AIDS . 8 . Renal hepatic dysfunction ( ALT , AST â‰¥ 1.5 time normal maximum level , Cr &gt; normal maximum level ) ; 9 . Confirmed suspected alcohol/drug abuse record ; 10 . Neurological psychiatric disease lead inability cooperation willing follow protocol instruction ; 11 . Feminine patient gestational , lactation period birth plan shortterm ; 12 . Enrolled clinical trial past 3 month ; 13 . Not suitable trial accord investigator 's judgment ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>safety bioavailability</keyword>
</DOC>